Orthobiologics Market, by Product Type (Bone Allograft, Machined Bones, Demineralized Bone Matrix, Synthetic Bone Substitutes, Bone Morphogenetic Protein (BMP), Stem Cell Therapy, Viscosupplementation), by Application (Spinal Fusion, Trauma, Reconstructiv

Orthobiologics Market, by Product Type (Bone Allograft, Machined Bones, Demineralized Bone Matrix, Synthetic Bone Substitutes, Bone Morphogenetic Protein (BMP), Stem Cell Therapy, Viscosupplementation), by Application (Spinal Fusion, Trauma, Reconstructive Surgeries), by End User (Hospitals, Ambulatory Surgical Centers, and Orthopedic Center), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Orthobiologics are substances that are used to heal injuries such as fractures and injured muscles, ligaments, and tendons within a short period of time. Orthobiologics are made from substances that naturally occur in the body. Orthobiologics help to improve the healing of broken bones and injured muscles, tendons and ligaments. These products are often made from substances that are naturally found in body. When they are used in higher concentrations, they may help speed up the healing process.Some examples of orthobiologics are bone grafts, autologous blood, autologous conditioned serum,platelet richplasma,growth factors, and stem cells. Orthobiologics are derived from a patient’s own tissues, such as bone marrow or blood hat are filled with signalling molecules or cells which stimulate and enhance the repair of musculoskeletal injuries. One can think of it as a treatment aimed at restoring joint function by harnessing the natural healing processes of the body. Orthobiologics can help delay or avoid more invasive treatments. Increasing prevalence of injury and facture due to falls and road accidents along with increasing prevalence of chronic arthritis are expected to augment growth of the orthobiologics market.

Market Dynamics

Increasing adoption of inorganic strategies such as product launches by key market players is expected to drive the global orthobiologics market growth over the forecast period. For instance, in July 2020, Spine Wave, Inc., a medical device company, announced that it had launched Tempest allograft bone matrix, which is composed of cancellous and partially demineralized cortical bone. Tempest allograft bone matrix yields a bone allograft that is both osteoconductive and osteoinductive to support bone growth and cellular migration.

Key features of the study:

• This report provides an in-depth analysis of the global orthobiologics market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global orthobiologics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Zimmer Biomet, Bone Biologics Corp., Globus Medical, Smith & Nephew Inc., Stryker, ATEC Spine, Inc., XTANT MEDICAL, Johnson & Johnson Services, Inc., Exactech, Inc., Integra LifeSciences, Medtronic, NuVasive, Inc., Orthofix US LLC., SeaSpine, ChitogenX Inc., Spine Wave, Inc., Molecular Matrix, Inc., Isto Biologics, Baxter, Locate Bio Limited, Cerapedics, Ossifix Orthopedics, and Aziyo
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global orthobiologics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global orthobiologics market

Detailed Segmentation:

• Global Orthobiologics Market, By Product Type:
• Bone Allograft
• Machined Bones
• Demineralized Bone Matrix
• Synthetic Bone Substitutes
• Bone Morphogenetic Protein (BMP)
• Stem Cell Therapy
• Viscosupplementation
• Global Orthobiologics Market, By Application:
• Spinal Fusion
• Trauma
• Reconstructive Surgeries
• Global Orthobiologics Market, By End User:
• Hospitals
• Ambulatory Surgical Centers
• Orthopedic Center
• Global Orthobiologics Market, By Region:
• North America
• By Country
• U.S.
• Canada
• Latin America
• By Country
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country
• GCC
• Israel
• Rest of Middle East
• Africa
• By Country/Regions
• South Africa
• Central Africa
• North Africa
• Company Profiles
• Zimmer Biomet*
• Company Highlights
• Products Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Bone Biologics Corp.
• Globus Medical
• Smith & Nephew Inc.
• Stryker
• ATEC Spine, Inc.
• XTANT MEDICAL
• Johnson & Johnson Services, Inc.
• Exactech, Inc.
• Integra LifeSciences
• Medtronic
• NuVasive, Inc.
• Orthofix US LLC.
• SeaSpine
• ChitogenX Inc.
• Spine Wave, Inc.
• Molecular Matrix, Inc.
• Isto Biologics
• Baxter
• Locate Bio Limited
• Cerapedics
• Ossifix Orthopedics
• Aziyo

“*” marked represents similar segmentation in other categories in the respective section.